NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/08/2024
Voltar para busca
Dado oficial do USPTO
LANDMARK BIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LANDMARK BIO
ST13
US500000090981066Classe
40, 42, 44
Pedido
90981066
Registro
7475592
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
13/08/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
40, 42, 44
Data de depósito
06/07/2021
Data de registro
13/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/08/2024
Última transação
13/08/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2021-05-00
Primeiro uso no comércio
2023-11-00
Código do desenho
4
Tipo de titular
99
Localização do titular
Watertown, MA
Examinador
DEFORD, JEFFREY
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LANDMARK BIO, PBLLC
The Center for Advanced Biological Innovation and Manufacturing, PBLLC
Representantes
Jessica L. Rothstein GOODWIN PROCTER LLP
Classificação técnica
Classes Nice
Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Custom manufacturing of bio-pharmaceuticals and reagents for others; Bio-manufacturing for othersmanufacturing of pharmaceuticals and reagents using biological organisms and chemical synthesis in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing and bio-manufacturing; Consulting services in the field of manufacturing processes for pharmaceuticals and bio-pharmaceuticals
Classe 42
Research and development of pharmaceuticals and bio-pharmaceuticals; research and development in the field of manufacturing processes for pharmaceuticals and bio-pharmaceuticals; technological servicestechnological consultation and research in the field of new product development in the pharmaceutical and health care industries; scientific analysis and researchevaluation of pharmaceutical products; scientific research and development with regard to medicines; product developmentpreparation of pharmaceutical test products; advisory services relating to scientific researchdevelopment and analyses of medicines and not for the diagnosis and treatment of humans or animals; development of new technologies in the biotechnology sector; providing information with regard to scientific research in the field of biochemistry and biotechnology; research and development of technologies used in manufacturingtesting and data analytics related bio-manufacturing; providing scientific information in the field of pharmaceutical manufacturing and bio-manufacturing
Classe 44
Advisory services relating to analyses of medicines for the diagnosis and treatment of humans or animals
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
13/08/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
21/06/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14/06/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
14/06/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
21/05/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
21/05/2024
EX2G
SOU EXTENSION 2 GRANTED
21/05/2024
IUAF
USE AMENDMENT FILED
03/04/2024
DRRR
DIVISIONAL REQUEST RECEIVED
03/04/2024
EXT2
SOU EXTENSION 2 FILED
03/04/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/04/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/10/2023
EX1G
SOU EXTENSION 1 GRANTED
13/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
13/10/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/10/2023
EXT1
SOU EXTENSION 1 FILED
03/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2023
PUBO
PUBLISHED FOR OPPOSITION
07/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/12/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/12/2022
GNRT
NON-FINAL ACTION E-MAILED
05/12/2022
CNRT
NON-FINAL ACTION WRITTEN
05/12/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
28/11/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/03/2022
GNRT
NON-FINAL ACTION E-MAILED
28/03/2022
CNRT
NON-FINAL ACTION WRITTEN
28/03/2022
DOCK
ASSIGNED TO EXAMINER
24/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2021
NWAP
NEW APPLICATION ENTERED
09/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LANDMARK BIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.